SCHEMBL6806299

SCHEMBL6806299

O=[N+]([O-])c1ccc2c(c1)CCN2Cc1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 1/20 0.49
DDB1 Q16531 1/20 0.47
CRBN Q96SW2 1/20 0.47
HTR2C P28335 1/20 0.43
MAPK1 P28482 2/20 0.42
CFTR P13569 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
ROCK1 Q13464 1/20 0.41
DRD4 P21917 1/20 0.41
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
ERBB4 Q15303 1/20 0.41
SERPINE1 P05121 1/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803901 0.88 ALDH1A1 (0.47) ALDH1A1KDM4EHTR2CMAPK1L3MBTL1
SCHEMBL16494700 0.85 NPC1 (0.42) ALDH1A1KDM4EDDB1CRBNHTR2C
SCHEMBL27376459 0.81 BRD4 (0.48) ALDH1A1KDM4ECFTRL3MBTL1CYP1A2
SCHEMBL30806562 0.81 BRD4 (0.48) ALDH1A1KDM4ECFTRL3MBTL1CYP1A2
SCHEMBL2769306 0.81 CASP1 (0.51) ALDH1A1MAPK1CYP1A2CYP3A4DRD4
SCHEMBL6501814 0.80 HTR2C (0.53) ALDH1A1KDM4EHTR2CL3MBTL1CYP1A2
Quinoline SCHEMBL28271845 0.79 HTR2C (0.41) ALDH1A1KDM4EHTR2CMAPK1CFTR
SCHEMBL6801884 0.79 ROCK1 (0.47) ALDH1A1KDM4EMAPK1L3MBTL1CYP1A2
SCHEMBL16494722 0.79 DDB1 (0.49) ALDH1A1KDM4EDDB1CRBNHTR2C
SCHEMBL6644024 0.78 TRPM5 (0.45) ALDH1A1KDM4EL3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 ALDH1A1 2901/4885KDM4E 2600/4885DDB1 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.